TrialPanorama/TrialPanorama-database huggingface dataset:
Study 33486783 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33486783 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33486783 — Predictive Biomarker (PRD): Hormone receptor
Study 33874898 — Surrogate Endpoint (SUR): Blood pressure
Study 32091536 — Predictive Biomarker (PRD): ABCD2 mRNA
Genes: ABCD2; ALD1; ALDL1; ALDR; ALDRP
Study 34244155 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36253020 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 34050550 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34050550 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33113552 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 34653328 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 34893133 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study 35349214 — Surrogate Endpoint (SUR): Blood pressure
Study 32103926 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 32103926 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 32762226 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 35470006 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 32860109 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35430800 — Predictive Biomarker (PRD): PLA2G1B mRNA
Genes: PLA2G1B; PLA2; PLA2A; PPLA2
Study 33730350 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35184413 — Predictive Biomarker (PRD): GSDMD mRNA
Genes: GSDMD; DFNA5L; GSDMDC1; FKSG10
Study 35184413 — Predictive Biomarker (PRD): GSDME mRNA
Genes: GSDME; DFNA5; ICERE1
Study 35050320 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 32063406 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32063406 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32063406 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 32063406 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 32063406 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study 36177926 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MUC5AC mRNA
Genes: MUC5AC; MUC5
Study 36177926 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36177926 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 33289149 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 36344108 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 35302400 — Predictive Biomarker (PRD): PCSK7 mRNA
Genes: PCSK7; LPC; PC7; PC8; SPC7
Study 33709920 — Surrogate Endpoint (SUR): Blood pressure
Study 34756882 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 34913976 — Surrogate Endpoint (SUR): Blood pressure
Study 32326948 — Surrogate Endpoint (SUR): Blood pressure
Study 33932526 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33627253 — Predictive Biomarker (PRD): MBL2 mRNA
Genes: MBL2; COLEC1; MBL
Study 32690640 — Surrogate Endpoint (SUR): Blood pressure
Study 33146720 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34611470 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 34510174 — Surrogate Endpoint (SUR): Blood pressure
Study 34114501 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34015041 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33137120 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 36454580 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34779542 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 34779542 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34515160 — Surrogate Endpoint (SUR): Blood pressure
Study 33839692 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 33067301 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33067301 — Surrogate Endpoint (SUR): Blood pressure
Study 34202167 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study 34202167 — Predictive Biomarker (PRD): GPIHBP1 mRNA
Genes: GPIHBP1; HBP1
Study 34202167 — Predictive Biomarker (PRD): LIPC mRNA
Genes: LIPC; HTGL
Study 34202167 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 34202167 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 35435961 — Safety Biomarker (SAF): CDA
Genes: CDD
Study 35228493 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 35228493 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35228493 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 34487151 — Monitoring Biomarker (MOI): HBV DNA
Study 34487151 — Surrogate Endpoint (SUR): Serum creatinine
Study 34487151 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 35437951 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34574456 — Safety Biomarker (SAF): Hydroxyphenylpyruvate dioxygenase
Genes: HPD; PPD
Study 34843964 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study 34344706 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34344706 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34605045 — Predictive Biomarker (PRD): SERPINH1 mRNA
Genes: SERPINH1; CBP1; CBP2; HSP47; SERPINH2; PIG14
Study 33243605 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34635391 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 34635391 — Safety Biomarker (SAF): HLA-DRB1
Genes: HLA-DR1B
Study 33253816 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 34543890 — Predictive Biomarker (PRD): FADS2 mRNA
Genes: FADS2
Study 33422811 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 32803709 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 33651675 — Predictive Biomarker (PRD): CCL17 mRNA
Genes: CCL17; SCYA17; TARC
Study 33651675 — Safety Biomarker (SAF): T-cell specific protein RANTES
Genes: CCL5; D17S136E; SCYA5
Study 36604812 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36604812 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36604812 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 36604812 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 36604812 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 33495134 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study 33495134 — Predictive Biomarker (PRD): PCSK5 mRNA
Genes: PCSK5; PC5; PC6
Study 32725848 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 32798927 — Predictive Biomarker (PRD): CARS1 mRNA
Genes: CARS1; CARS
Study 34409492 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 34260036 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32646498 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 32646498 — Surrogate Endpoint (SUR): Blood pressure
Study 33636823 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study 34053746 — Surrogate Endpoint (SUR): Pathological complete response
Study 33725780 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33374147 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 33374147 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 35852458 — Surrogate Endpoint (SUR): Blood pressure
Study 33682603 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 36485155 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 32560734 — Predictive Biomarker (PRD): POR mRNA
Genes: POR; CYPOR
Study 34112513 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study 32472628 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35039035 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 32963704 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32963704 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32963704 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 35791320 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 36370066 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33909607 — Surrogate Endpoint (SUR): Blood pressure
Study 35552093 — Predictive Biomarker (PRD): DRD2 mRNA
Genes: DRD2
Study 35552093 — Predictive Biomarker (PRD): ADORA2A mRNA
Genes: ADORA2A; ADORA2
Study 36364823 — Surrogate Endpoint (SUR): Blood pressure
Study 35260961 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 32380746 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32722083 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33166989 — Surrogate Endpoint (SUR): Blood pressure
Study 33159735 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 34620406 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34203181 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 34203181 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35243872 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 34984835 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study 34984835 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC2A4 mRNA
Genes: SLC2A4; GLUT4
Study 34984835 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34984835 — Predictive Biomarker (PRD): UCP3 mRNA
Genes: UCP3; SLC25A9
Study 34984835 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 34984835 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 33899216 — Surrogate Endpoint (SUR): Blood pressure
Study 33899216 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32027744 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 32027744 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 32027744 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study 35889755 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 35889755 — Surrogate Endpoint (SUR): Serum creatinine
Study 32624400 — Predictive Biomarker (PRD): NXF1 mRNA
Genes: NXF1; TAP
Study 34945780 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34945780 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33188886 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 33188886 — Surrogate Endpoint (SUR): Serum creatinine
Study 34843023 — Safety Biomarker (SAF): Hyaluronic acid
Study 34035391 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 34035391 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study 34035391 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 34035391 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 34035391 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study 32494981 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35876124 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 33064299 — Surrogate Endpoint (SUR): Serum uric acid
Study 33435475 — Surrogate Endpoint (SUR): Blood pressure
Study 34255069 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 33097092 — Predictive Biomarker (PRD): Hormone receptor
Study 32745703 — Predictive Biomarker (PRD): COPE mRNA
Genes: COPE
Study 34791813 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34446487 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33077895 — Predictive Biomarker (PRD): WWTR1 mRNA
Genes: WWTR1; TAZ
Study 35696725 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 35696725 — Safety Biomarker (SAF): Reactive oxygen species
Study 32537847 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 33010766 — Predictive Biomarker (PRD): CFP mRNA
Genes: CFP; PFC
Study 32704082 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33400390 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 32030695 — Surrogate Endpoint (SUR): Blood pressure
Study 35711611 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 35124474 — Predictive Biomarker (PRD): NNT mRNA
Genes: NNT
Study 32062494 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Placenta growth factor
Genes: PGF; PGFL; PLGF
Study 34112285 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34112285 — Monitoring Biomarker (MOI): Procalcitonin
Study 34112285 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34112285 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34112285 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 35507901 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 34358675 — Surrogate Endpoint (SUR): Serum creatinine
Study 34989143 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34989143 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32141968 — Surrogate Endpoint (SUR): Blood pressure
Study 33293342 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 34618221 — Surrogate Endpoint (SUR): Blood pressure
Study 33740736 — Surrogate Endpoint (SUR): Blood pressure
Study 36039026 — Surrogate Endpoint (SUR): Serum creatinine
Study 36136304 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32274634 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 32584426 — Predictive Biomarker (PRD): RICTOR mRNA
Genes: RICTOR; KIAA1999
Study 32584426 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 32584426 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study 32584426 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 35099501 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33487257 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33487257 — Surrogate Endpoint (SUR): Serum uric acid
Study 34080761 — Predictive Biomarker (PRD): RIT1 mRNA
Genes: RIT1; RIBB; RIT; ROC1
Study 35498440 — Predictive Biomarker (PRD): 40S ribosomal protein S6
Genes: RPS6; OK/SW-cl.2
Study 35498440 — Predictive Biomarker (PRD): UBR5 mRNA
Genes: UBR5; EDD; EDD1; HYD; KIAA0896
Study 35498440 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study 35498440 — Predictive Biomarker (PRD): ULK1 mRNA
Genes: ULK1; KIAA0722
Study 35498440 — Predictive Biomarker (PRD): BNIP3 mRNA
Genes: BNIP3; NIP3
Study 35498440 — Predictive Biomarker (PRD): FIS1 mRNA
Genes: FIS1; TTC11; CGI-135
Study 33849113 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33849113 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33849113 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33707768 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study 34533039 — Predictive Biomarker (PRD): CYBB mRNA
Genes: CYBB; NOX2
Study 34533039 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34533039 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34533039 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 35531796 — Safety Biomarker (SAF): Hyaluronic acid
Study 35686561 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 35686561 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35686561 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35686561 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33740316 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study 33280218 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 33684552 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34407542 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 35717662 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study 34154590 — Surrogate Endpoint (SUR): Bone mineral density
Study 32384434 — Predictive Biomarker (PRD): SP6 mRNA
Genes: SP6; KLF14
Study 33183068 — Surrogate Endpoint (SUR): Bone mineral density
Study 34332606 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study 34477813 — Predictive Biomarker (PRD): IKZF1 mRNA
Genes: IKZF1; IK1; IKAROS; LYF1; ZNFN1A1
Study 34477813 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 34477813 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 32353822 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32353822 — Monitoring Biomarker (MOI): Procalcitonin
Study 32520577 — Safety Biomarker (SAF): Reactive oxygen species
Study 35833783 — Safety Biomarker (SAF): Reactive oxygen species
Study 34370612 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 32898379 — Safety Biomarker (SAF): Hyaluronic acid
Study 35973655 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 35377447 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35377447 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 32667902 — Surrogate Endpoint (SUR): Serum sodium
Study 34271948 — Surrogate Endpoint (SUR): Blood pressure
Study 36191453 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 34769711 — Surrogate Endpoint (SUR): Blood pressure
Study 33586143 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study 35724559 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35724559 — Predictive Biomarker (PRD): EDA mRNA
Genes: EDA; ED1; EDA2
Study 32968194 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 33290813 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 32495306 — Surrogate Endpoint (SUR): Blood pressure
Study 33566149 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 33566149 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 34008144 — Safety Biomarker (SAF): Interleukin 1
Study 35972817 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 33431381 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 33104216 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 35435472 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 35435472 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 32282591 — Surrogate Endpoint (SUR): Blood pressure
Study 35549686 — Predictive Biomarker (PRD): AIP mRNA
Genes: AIP; XAP2
Study 34680131 — Safety Biomarker (SAF): Hyaluronic acid
Study 34845555 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 34682399 — Predictive Biomarker (PRD): LIPC mRNA
Genes: LIPC; HTGL
Study 34196106 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study 34196106 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 36052684 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 36052684 — Surrogate Endpoint (SUR): Blood pressure
Study 34488362 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34488362 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 34488362 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2